sports | Business | Health | food | Technology | money |
Roche’s arthritis drug tocilizumab cuts the risk of death among patients hospitalized with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, a large clinical trial suggests.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.